FCM MM Holdings Condemns ISS Report on Mind Medicine (MNMD)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall St kicks off September under pressure as higher yields, oil prices weigh
- Oil prices rise 2% as US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
- The Warsh pivot markets didn't expect
ISS Appears to Rely on MindMed's False and Misleading Statements to Justify the Company's Abysmal Performance; Seemingly Ignores MindMed's Apparent Disregard of Patient Safety
June 5, 2023 6:19 AM EDTISS Dismissed 47% Stock Price Drop Following September 2022 Financing as In Line with Sectoral Trends, in a Baffling Lack of Critical Analysis and Seemingly in Opposition to the Factual Circumstances
After Recommending Removal of Chair Vallone in 2022, ISS Appears to Blindly Accept Vallones and MindMeds Justifications for Poor Development Decisions, Destructive Financing, and Bloated Compensation
ISS Report Reiterates MindMeds False Statements About General and Administrative Costs; Ignores FCMs Explicit Refutation
Flawed and Superficial ISS Analysis of MindMeds Clinical Strategy Leans Heavily on... More
